PHILADELPHIA & FAIRFAX, Va.--(BUSINESS WIRE)--Chimeron Bio, an RNA therapeutics company, and George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID), a leading ...
PHILADELPHIA,Pa & FAIRFAX, Va.-- Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID), a leading institute conducting ...
Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases (NCBID), a leading institute conducting pioneering research on ...